URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Edward Walsh

Concepts (356)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Respiratory Syncytial Virus Infections
36
1994
90
10.930
Why?
Respiratory Syncytial Viruses
54
1983
105
7.660
Why?
Antibodies, Viral
45
1984
456
6.360
Why?
Respiratory Syncytial Virus, Human
19
1994
36
5.250
Why?
Reverse Transcriptase Polymerase Chain Reaction
17
2001
543
3.790
Why?
Respiratory Tract Infections
17
1983
133
3.710
Why?
Metapneumovirus
7
2003
11
3.400
Why?
Paramyxoviridae Infections
7
1999
26
3.320
Why?
Viral Envelope Proteins
25
1984
86
3.290
Why?
Virus Diseases
5
1992
73
2.820
Why?
Influenza A virus
12
1987
218
2.680
Why?
Antiviral Agents
7
1983
170
2.610
Why?
Influenza, Human
13
1987
345
2.570
Why?
Nasal Mucosa
12
1986
49
2.060
Why?
Influenza B virus
3
2007
42
1.980
Why?
Viral Fusion Proteins
19
1985
37
1.930
Why?
Viral Vaccines
12
1986
105
1.890
Why?
Viral Proteins
23
1983
214
1.880
Why?
Aged
43
1990
7392
1.800
Why?
Neutralization Tests
22
1983
128
1.800
Why?
Antigens, Viral
21
1985
144
1.740
Why?
Sputum
3
2007
45
1.720
Why?
Pulmonary Disease, Chronic Obstructive
3
2005
98
1.690
Why?
Molecular Diagnostic Techniques
2
2011
8
1.690
Why?
Virology
2
2011
20
1.680
Why?
HN Protein
9
1988
33
1.650
Why?
Antibodies, Neutralizing
3
2009
34
1.580
Why?
Epitopes
7
1986
208
1.510
Why?
Respirovirus Infections
23
1983
61
1.470
Why?
Influenza Vaccines
4
2007
269
1.400
Why?
Aged, 80 and over
24
1992
2588
1.390
Why?
Specimen Handling
3
1999
72
1.320
Why?
Adult
37
1983
11572
1.310
Why?
Humans
89
1983
37165
1.290
Why?
Immunoglobulin G
21
1984
494
1.150
Why?
Antibody-Producing Cells
3
2010
32
1.140
Why?
Viruses
3
1992
23
1.090
Why?
Middle Aged
29
1996
10013
1.090
Why?
Female
45
1983
20222
1.020
Why?
Male
43
1983
20139
0.980
Why?
Respiratory Syncytial Virus Vaccines
2
2008
9
0.920
Why?
Immunity, Humoral
2
2009
17
0.910
Why?
Hospitalization
10
1997
385
0.900
Why?
Climate
1
2011
4
0.840
Why?
Calcitonin
1
2012
42
0.840
Why?
Pneumonia, Bacterial
1
2012
17
0.840
Why?
Sialic Acids
1
2011
32
0.820
Why?
Protein Precursors
1
2012
84
0.810
Why?
Influenza A Virus, H3N2 Subtype
1
2011
61
0.790
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2011
46
0.790
Why?
Antibodies, Monoclonal
14
1983
748
0.780
Why?
Mupirocin
1
2010
3
0.770
Why?
RNA, Viral
4
2001
294
0.770
Why?
Prospective Studies
11
1990
1696
0.770
Why?
Sensitivity and Specificity
8
1999
914
0.770
Why?
Bacterial Infections
1
2012
129
0.770
Why?
Infection Control
1
2010
22
0.760
Why?
Methicillin-Resistant Staphylococcus aureus
1
2010
18
0.750
Why?
Surgical Wound Infection
1
2010
59
0.730
Why?
Epitope Mapping
1
2010
29
0.730
Why?
Pneumonia
1
2012
192
0.720
Why?
Staphylococcal Infections
1
2010
106
0.700
Why?
Capsid Proteins
1
2009
32
0.700
Why?
Oncogene Proteins, Viral
1
2009
44
0.690
Why?
Cardiac Surgical Procedures
1
2010
83
0.690
Why?
Pneumonia, Viral
2
2005
22
0.680
Why?
Immunoenzyme Techniques
7
1987
214
0.680
Why?
New York
9
1990
1378
0.680
Why?
Inpatients
5
1990
69
0.670
Why?
Anti-Bacterial Agents
2
2007
442
0.670
Why?
Coronavirus Infections
3
1999
12
0.660
Why?
Heart Failure
2
1999
360
0.660
Why?
Disease Outbreaks
3
1990
115
0.610
Why?
Coronavirus
2
2003
9
0.600
Why?
Homes for the Aged
4
1992
58
0.590
Why?
Myocardial Infarction
1
2011
651
0.580
Why?
Immunoglobulin A, Secretory
5
1986
21
0.550
Why?
Nursing Homes
5
1990
192
0.550
Why?
Vaccination
7
1986
254
0.530
Why?
DNA, Viral
1
2007
310
0.520
Why?
Yellow fever virus
3
1985
30
0.510
Why?
Diagnosis, Differential
4
2003
889
0.480
Why?
Ribavirin
5
1983
44
0.480
Why?
Virus Shedding
1
2003
9
0.480
Why?
Severe Acute Respiratory Syndrome
1
2003
5
0.460
Why?
Aging
3
1986
705
0.390
Why?
Incidence
4
1990
682
0.380
Why?
Membrane Glycoproteins
8
1986
376
0.370
Why?
Enzyme-Linked Immunosorbent Assay
14
1986
472
0.360
Why?
Vaccines, Synthetic
2
1994
88
0.360
Why?
Lung Diseases, Obstructive
1
1999
43
0.350
Why?
Risk Factors
7
1990
2331
0.350
Why?
Pharynx
2
2007
39
0.350
Why?
Immunization, Passive
5
1984
65
0.350
Why?
Young Adult
5
2008
1084
0.340
Why?
Infant
17
1983
2320
0.340
Why?
Time Factors
7
1987
3234
0.340
Why?
Immunoglobulin A
6
1986
88
0.340
Why?
Nose
2
2006
50
0.340
Why?
Amino Acid Sequence
3
1998
1227
0.340
Why?
Glycoproteins
11
1983
208
0.330
Why?
Frail Elderly
1
1999
60
0.330
Why?
Antibody Formation
6
1987
178
0.330
Why?
Vero Cells
4
1990
56
0.330
Why?
Yellow Fever
2
1985
15
0.330
Why?
Leukocytes, Mononuclear
4
1991
112
0.310
Why?
Immunologic Memory
2
2005
129
0.300
Why?
Predictive Value of Tests
2
2007
609
0.300
Why?
Cohort Studies
3
2003
984
0.300
Why?
Immunization
5
1987
188
0.300
Why?
Administration, Intranasal
4
1994
61
0.300
Why?
Molecular Sequence Data
3
1998
2046
0.300
Why?
Animals
23
1983
16416
0.290
Why?
Risk Assessment
2
2010
875
0.290
Why?
B-Lymphocytes
3
1999
479
0.280
Why?
Immunocompromised Host
2
2000
85
0.280
Why?
Heart Diseases
3
2002
138
0.260
Why?
Mice, Inbred BALB C
5
1985
625
0.260
Why?
Logistic Models
3
2009
626
0.250
Why?
Chronic Disease
3
1997
554
0.250
Why?
Interferon-gamma
2
2005
341
0.250
Why?
Lung Diseases
3
2002
224
0.250
Why?
Viral Load
4
2003
141
0.250
Why?
Treatment Outcome
4
2007
2671
0.240
Why?
Cell Transformation, Viral
3
1987
48
0.240
Why?
Antibodies, Monoclonal, Humanized
2
2009
94
0.240
Why?
Mice
11
1985
6206
0.240
Why?
Mutation
3
1983
1226
0.240
Why?
Chlamydophila pneumoniae
1
1993
8
0.240
Why?
Immunity, Mucosal
3
1999
22
0.240
Why?
Chlamydia Infections
1
1993
21
0.230
Why?
Nasopharynx
2
2003
47
0.230
Why?
Cell Line
9
1983
1623
0.220
Why?
United States
3
2007
2847
0.220
Why?
Confounding Factors (Epidemiology)
2
1990
60
0.200
Why?
Bystander Effect
1
2011
2
0.200
Why?
Enzyme-Linked Immunospot Assay
1
2010
4
0.200
Why?
Ointments
1
2010
9
0.190
Why?
Hep G2 Cells
1
2010
8
0.190
Why?
Multivariate Analysis
2
1990
548
0.190
Why?
Vancomycin
1
2010
30
0.190
Why?
Biological Markers
2
2001
564
0.190
Why?
Antibiotic Prophylaxis
1
2010
34
0.180
Why?
Viral Core Proteins
1
1990
23
0.180
Why?
Capsid
1
1990
36
0.180
Why?
Cholera Toxin
3
1993
26
0.180
Why?
Molecular Weight
6
1983
372
0.180
Why?
Antigens, Surface
1
1990
100
0.180
Why?
Up-Regulation
1
2012
375
0.180
Why?
Glycosaminoglycans
1
2009
22
0.180
Why?
Vaccines, Virosome
1
2009
3
0.180
Why?
Glucocorticoids
1
2011
168
0.180
Why?
Retrospective Studies
2
2005
2302
0.180
Why?
Respiratory Insufficiency
1
2009
57
0.180
Why?
RNA Interference
1
2010
138
0.180
Why?
Disease Progression
1
2012
533
0.180
Why?
Alum Compounds
1
2008
4
0.170
Why?
Recombinant Fusion Proteins
2
1994
392
0.170
Why?
Severity of Illness Index
3
2007
943
0.160
Why?
Research Design
1
2010
340
0.160
Why?
Rimantadine
1
2007
9
0.150
Why?
Zanamivir
1
2007
12
0.150
Why?
Oseltamivir
1
2007
9
0.150
Why?
Protein Structure, Tertiary
1
2009
382
0.150
Why?
Amantadine
1
2007
21
0.150
Why?
Centers for Disease Control and Prevention (U.S.)
1
2007
23
0.150
Why?
Models, Molecular
1
2009
366
0.150
Why?
Acute Disease
3
1992
591
0.140
Why?
Double-Blind Method
5
1983
996
0.140
Why?
Age Factors
4
1990
1152
0.140
Why?
Health Services for the Aged
1
2007
64
0.140
Why?
Respirovirus
1
2006
9
0.140
Why?
Child, Preschool
6
1983
2737
0.140
Why?
Rhinovirus
1
2006
16
0.140
Why?
Antibody Specificity
5
1986
108
0.140
Why?
Orthomyxoviridae
1
2006
59
0.130
Why?
Cytokines
3
2000
575
0.130
Why?
Encephalitis
1
1985
56
0.130
Why?
Interleukin-10
1
2005
100
0.130
Why?
Adjuvants, Immunologic
3
1993
118
0.120
Why?
Long-Term Care
1
2005
65
0.120
Why?
Health Services
1
2005
76
0.120
Why?
Practice Guidelines as Topic
1
2007
319
0.120
Why?
Virus Cultivation
1
2003
29
0.120
Why?
Seroepidemiologic Studies
2
1998
12
0.120
Why?
Hong Kong
1
2003
22
0.120
Why?
Causality
1
2003
43
0.110
Why?
Chromatography, Affinity
3
1984
92
0.110
Why?
World Health Organization
1
2003
41
0.110
Why?
Seasons
3
1990
91
0.110
Why?
Vaccines, Attenuated
3
1986
86
0.110
Why?
Cough
1
2002
24
0.110
Why?
Common Cold
1
2002
10
0.110
Why?
Antigen-Antibody Complex
3
1983
56
0.110
Why?
CD4-Positive T-Lymphocytes
1
2005
298
0.110
Why?
Infant, Newborn
6
1983
1836
0.100
Why?
Fever
1
2002
109
0.100
Why?
Blotting, Western
2
1989
672
0.100
Why?
Recurrence
5
1985
697
0.100
Why?
Apolipoproteins
1
2001
39
0.100
Why?
Antigens, CD14
1
2000
13
0.100
Why?
Immunoglobulin E
1
2001
56
0.100
Why?
Follow-Up Studies
1
2005
1889
0.090
Why?
Lung
6
1983
1148
0.090
Why?
C-Reactive Protein
1
2001
117
0.090
Why?
Picornaviridae Infections
1
1999
11
0.090
Why?
Drosophila Proteins
1
2000
76
0.090
Why?
Arvicolinae
4
1984
7
0.090
Why?
Dose-Response Relationship, Immunologic
2
1994
57
0.090
Why?
Adolescent
5
2000
5044
0.090
Why?
Formaldehyde
3
1986
24
0.090
Why?
Confidence Intervals
1
1999
164
0.080
Why?
Receptors, Cell Surface
1
2000
217
0.080
Why?
Neoplasms, Experimental
1
1999
149
0.080
Why?
Attachment Sites, Microbiological
1
1998
4
0.080
Why?
Kinetics
2
1990
1471
0.080
Why?
Fluorescent Antibody Technique, Indirect
1
1998
43
0.080
Why?
Cross Reactions
4
1987
115
0.080
Why?
Cells, Cultured
4
1985
2589
0.080
Why?
Complement System Proteins
2
1985
114
0.080
Why?
Binding, Competitive
2
1986
210
0.080
Why?
Safety
1
1997
106
0.070
Why?
Asthma
1
2001
314
0.070
Why?
Disease Transmission, Infectious
1
1996
12
0.070
Why?
Risk
1
1998
355
0.070
Why?
Aerosols
3
1983
115
0.070
Why?
Electrophoresis, Polyacrylamide Gel
2
1983
387
0.070
Why?
Macrophages
3
1985
347
0.070
Why?
Statistics, Nonparametric
2
2001
269
0.070
Why?
Reproducibility of Results
1
1999
903
0.070
Why?
Tumor Cells, Cultured
1
1998
886
0.070
Why?
Lymphocytes
2
1985
298
0.070
Why?
Fluorescent Antibody Technique
3
1983
307
0.060
Why?
Immunization, Secondary
1
1994
72
0.060
Why?
Environmental Microbiology
1
1993
2
0.060
Why?
Cell Culture Techniques
2
2003
94
0.060
Why?
Ribonucleosides
2
1983
19
0.060
Why?
T-Lymphocytes, Cytotoxic
1
1994
147
0.060
Why?
Base Sequence
1
1998
1721
0.060
Why?
Outpatients
2
1990
31
0.060
Why?
Bronchoalveolar Lavage Fluid
1
1994
301
0.060
Why?
Administration, Topical
1
1993
91
0.060
Why?
Disease Models, Animal
2
1992
974
0.050
Why?
Virus Replication
2
1986
307
0.050
Why?
Macromolecular Substances
1
1993
216
0.050
Why?
Peptide Fragments
1
1994
307
0.050
Why?
Reference Values
1
1993
453
0.050
Why?
Immunoglobulins, Intravenous
1
1992
37
0.050
Why?
Disease Susceptibility
1
1992
80
0.050
Why?
Flow Cytometry
2
1991
603
0.050
Why?
Adaptive Immunity
1
2011
8
0.050
Why?
Immunity
1
1992
65
0.050
Why?
Cross Infection
1
1992
85
0.050
Why?
Radioimmunoprecipitation Assay
1
1990
5
0.050
Why?
Skin
1
1993
384
0.050
Why?
T-Lymphocyte Subsets
1
2011
109
0.050
Why?
Autoradiography
1
1990
131
0.050
Why?
Hemagglutination Inhibition Tests
1
2010
74
0.050
Why?
Precipitin Tests
1
1990
124
0.050
Why?
Dose-Response Relationship, Drug
1
1993
1142
0.050
Why?
Antibody Affinity
1
2009
13
0.050
Why?
Viral Nonstructural Proteins
1
1990
32
0.050
Why?
Species Specificity
2
1987
342
0.050
Why?
Placebos
1
2010
185
0.040
Why?
Interleukin-1
1
1991
221
0.040
Why?
Kaplan-Meier Estimate
1
2010
207
0.040
Why?
RNA, Small Interfering
1
2010
208
0.040
Why?
Cercopithecus aethiops
1
2009
166
0.040
Why?
Vaccines, Inactivated
1
1988
40
0.040
Why?
Lymphocyte Activation
1
1991
414
0.040
Why?
Rabbits
1
1990
720
0.040
Why?
Cricetinae
1
2009
393
0.040
Why?
Monocytes
2
1985
317
0.040
Why?
Immune Sera
1
1987
79
0.040
Why?
Cell Membrane
1
1990
506
0.040
Why?
Interleukin-5
1
2007
40
0.040
Why?
Phytohemagglutinins
1
2007
55
0.040
Why?
Models, Biological
1
1993
1029
0.040
Why?
Croatia
1
2006
1
0.040
Why?
Epithelial Cells
1
2009
332
0.040
Why?
Recombinant Proteins
1
2009
770
0.040
Why?
Interleukin-4
1
2007
160
0.040
Why?
Membrane Fusion
1
1986
25
0.040
Why?
Immunity, Active
1
1985
9
0.030
Why?
Transfection
1
2009
887
0.030
Why?
Cytotoxicity Tests, Immunologic
1
1985
30
0.030
Why?
Mice, Inbred ICR
1
1985
82
0.030
Why?
Polymerase Chain Reaction
1
2007
597
0.030
Why?
Child
3
1989
4342
0.030
Why?
Cell Fusion
1
1984
24
0.030
Why?
Amino Acids
1
1985
230
0.030
Why?
Nucleoproteins
1
1983
17
0.030
Why?
CD8-Positive T-Lymphocytes
1
2005
229
0.030
Why?
Evaluation Studies as Topic
1
2003
247
0.030
Why?
Liver Neoplasms, Experimental
1
1983
32
0.030
Why?
Immunoassay
1
1983
40
0.030
Why?
Membrane Proteins
2
1983
560
0.030
Why?
Antigens, Bacterial
1
1983
93
0.030
Why?
Temperature
1
1983
247
0.030
Why?
Cattle
1
1983
560
0.030
Why?
Convalescence
1
2001
17
0.020
Why?
Serum Amyloid A Protein
1
2001
22
0.020
Why?
Respiratory Sounds
1
2001
19
0.020
Why?
Immunoglobulin Isotypes
2
1987
35
0.020
Why?
Rats
2
1983
4389
0.020
Why?
Toll-Like Receptor 4
1
2000
18
0.020
Why?
Injections, Intramuscular
2
1986
70
0.020
Why?
Toll-Like Receptors
1
2000
20
0.020
Why?
Length of Stay
1
2002
295
0.020
Why?
Dendritic Cells
1
2002
117
0.020
Why?
Inflammation Mediators
1
2000
113
0.020
Why?
Kidney
1
1983
589
0.020
Why?
Herpesvirus 4, Human
1
1999
66
0.020
Why?
Tumor Virus Infections
1
1999
61
0.020
Why?
Mice, SCID
1
1999
171
0.020
Why?
Herpesviridae Infections
1
1999
71
0.020
Why?
Drug Administration Schedule
1
2000
374
0.020
Why?
Immunoblotting
1
1999
225
0.020
Why?
Case-Control Studies
1
2001
624
0.020
Why?
Regression Analysis
1
2000
539
0.020
Why?
Spleen
1
1999
343
0.020
Why?
Longitudinal Studies
2
1987
413
0.020
Why?
Mice, Knockout
1
2000
922
0.020
Why?
Analysis of Variance
1
1999
749
0.020
Why?
Cross-Sectional Studies
1
1999
676
0.020
Why?
Sigmodontinae
1
1994
5
0.020
Why?
Mucous Membrane
1
1994
46
0.020
Why?
Respiratory System
1
1994
46
0.020
Why?
Random Allocation
2
1983
253
0.010
Why?
Blood Donors
1
1992
28
0.010
Why?
Receptors, Transferrin
1
1991
21
0.010
Why?
Receptors, Interleukin-2
1
1991
30
0.010
Why?
HLA-DR Antigens
1
1991
55
0.010
Why?
Pulse
1
1990
28
0.010
Why?
Respiration
1
1990
181
0.010
Why?
Carbon Dioxide
1
1990
213
0.010
Why?
Population Surveillance
1
1990
144
0.010
Why?
Clinical Trials as Topic
2
1983
685
0.010
Why?
Cell Cycle
1
1991
253
0.010
Why?
Cell Survival
1
1991
559
0.010
Why?
Infant, Premature
1
1990
229
0.010
Why?
Prevalence
1
1990
582
0.010
Why?
Sulfur Radioisotopes
1
1987
26
0.010
Why?
Vaccinia virus
1
1987
56
0.010
Why?
Methionine
1
1987
49
0.010
Why?
Immunity, Maternally-Acquired
1
1987
18
0.010
Why?
Oxygen
1
1990
495
0.010
Why?
Aotus trivirgatus
1
1985
4
0.010
Why?
Immunity, Innate
1
1987
103
0.010
Why?
Leukocyte Count
1
1985
162
0.010
Why?
T-Lymphocytes, Helper-Inducer
1
1985
92
0.010
Why?
T-Lymphocytes, Regulatory
1
1985
51
0.010
Why?
Neutrophils
1
1986
313
0.010
Why?
Respiratory Function Tests
1
1983
129
0.010
Why?
Microbial Sensitivity Tests
1
1983
170
0.010
Why?
Ribonucleoproteins
1
1983
59
0.010
Why?

Visualizations


Walsh's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department